Wei‐Hsin Hsu

501 citations
18 papers · 410 indexed · h-index 14
Topics
Nanoparticle-Based Drug Delivery (6 papers)Nanoplatforms for cancer theranostics (5 papers)Advanced biosensing and bioanalysis techniques (4 papers)

In The Last Decade

Wei‐Hsin Hsu

18 papers receiving 406 citations

Peers

Wei‐Hsin Hsu
Comparison fields: 5 of 78
  • Biomaterials 190
  • Biomedical Engineering 145
  • Molecular Biology 140
  • Polymers and Plastics 64
  • Organic Chemistry 62
Replace Dishi Wang with:
Dishi Wang Germany
Sarah S. Kermaniyan Australia
Miaomiao Long China
Shyam M. Garg Canada
Mahsa Shahriari Iran
Aida Varela-Moreira Netherlands
Fabiana Canal Spain
Sara Movassaghian United States
Pasquale Tirino Italy
Hemda Baabur‐Cohen Israel
Wei‐Hsin Hsu relative to Dishi Wang Germany Dishi Wang's profile →
Citations per field
00.5×1.5×2.4×
Dishi Wang · 1×
Citations per year

Countries citing papers authored by Wei‐Hsin Hsu

Since Specialization
Citations

This map shows the geographic impact of Wei‐Hsin Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Hsin Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Hsin Hsu more than expected).

Fields of papers citing papers by Wei‐Hsin Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Hsin Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Hsin Hsu. The network helps show where Wei‐Hsin Hsu may publish in the future.

Co-authorship network of co-authors of Wei‐Hsin Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Hsin Hsu. A scholar is included among the top collaborators of Wei‐Hsin Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Hsin Hsu. Wei‐Hsin Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 13
2 5
3 35
4 14
5 39
6 16
7 26
8 6
9 24
10 58
11 18
12 21
13 17
14 30
15 28
16 13
17 41
18 6

About Wei‐Hsin Hsu

Wei‐Hsin Hsu is a scholar working on Biomaterials, Orthodontics and Polymers and Plastics, having authored 18 papers that have together received 410 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (6 papers), Nanoplatforms for cancer theranostics (5 papers) and Advanced biosensing and bioanalysis techniques (4 papers). The work is most often cited by research in Biomaterials (190 citations), Molecular Medicine (33 citations) and Polymers and Plastics (64 citations). Wei‐Hsin Hsu has collaborated with scholars based in Taiwan, United Kingdom and Spain. Frequent co-authors include Hsieh‐Chih Tsai, Juin‐Yih Lai, Abegaz Tizazu Andrgie, Hsiao‐Ying Chou, Shuian‐Yin Lin, R. James Christie, Jem‐Mau Lo, Yihenew Simegniew Birhan, Haile Fentahun Darge and Endiries Yibru Hanurry. Their work appears in journals such as Journal of Controlled Release, Molecules and Acta Biomaterialia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026